BE641880A - - Google Patents
Info
- Publication number
- BE641880A BE641880A BE641880A BE641880A BE641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A
- Authority
- BE
- Belgium
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5790262 | 1962-12-27 | ||
| JP5741963 | 1963-10-29 | ||
| JP6427663 | 1963-10-29 | ||
| JP6250163 | 1963-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE641880A true BE641880A (OSRAM) | 1964-04-16 |
Family
ID=27463499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE641880A BE641880A (OSRAM) | 1962-12-27 | 1963-12-27 |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE641880A (OSRAM) |
| FR (1) | FR3150M (OSRAM) |
| GB (1) | GB1080599A (OSRAM) |
| LU (1) | LU45106A1 (OSRAM) |
| NL (1) | NL302572A (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107540413A (zh) * | 2017-09-14 | 2018-01-05 | 精晶药业股份有限公司 | 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2495608A1 (fr) * | 1980-12-04 | 1982-06-11 | Morelle Jean | Nouveaux derives de l'acide aspartique et leurs usages |
| US8389576B2 (en) | 2004-11-26 | 2013-03-05 | Ucl Business Plc | Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| DK3263100T3 (da) | 2009-04-03 | 2020-05-11 | Ocera Therapeutics Inc | L-ornithinphenylacetat og fremgangsmåder til fremstilling deraf |
| DK2440200T3 (en) | 2009-06-08 | 2014-12-08 | Ucl Business Plc | Treatment of portal hypertension in the application of l-ornithinphenylacetat |
| US8946473B2 (en) | 2010-10-06 | 2015-02-03 | Ocera Therapeutics, Inc. | Methods of making L-ornithine phenyl acetate |
| ES2769000T3 (es) | 2014-11-24 | 2020-06-24 | Ucl Business Ltd | Tratamiento de enfermedades asociadas con la activación de células estrelladas hepáticas utilizando terapias reductoras de amoníaco |
| US10835506B2 (en) | 2015-08-18 | 2020-11-17 | Ocera Therapeutics, Inc. | Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate |
| AU2018266357B2 (en) | 2017-05-11 | 2022-12-08 | Ocera Therapeutics, Inc. | Processes of making L-ornithine phenylacetate |
-
0
- NL NL302572D patent/NL302572A/xx unknown
-
1963
- 1963-12-23 GB GB50695/63A patent/GB1080599A/en not_active Expired
- 1963-12-23 LU LU45106D patent/LU45106A1/xx unknown
- 1963-12-26 FR FR958559A patent/FR3150M/fr active Active
- 1963-12-27 BE BE641880A patent/BE641880A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107540413A (zh) * | 2017-09-14 | 2018-01-05 | 精晶药业股份有限公司 | 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR3150M (fr) | 1965-02-22 |
| NL302572A (OSRAM) | |
| LU45106A1 (OSRAM) | 1964-02-24 |
| GB1080599A (en) | 1967-08-23 |